AI Driven Drug Discovery Summit 2024 - USA | Kisaco Research | 12 November 2024 | Aloft Boston Seaport District, 401-403 D St, Boston, MA 02210, USA

AI has saved drug developers 40% in costs through optimizing AI in the discovery stages. As of 2024, 95% of pharma companies are using AI in discovery phases and as drug development innovations soar, failure to implement AI-driven solutions is not only a missed opportunity, but a costly oversight.

In this dynamic field, it's crucial to identify where and how AI can provide most value. By uniting leaders from pharmaceuticals, biotech, AI tech, and academia, this forum provides a unique opportunity to develop a well-defined strategic vision with ambitious goals for harnessing AI’s potential to optimize the process of drug discovery.

Integration Strategies:
• Learn how to effectively integrate AI into existing drug discovery pipelines to accelerate research and development in your specific focus area. Explore various case studies and models that demonstrate successful AI implementation to understand the practical aspects and potential hurdles of AI adoption.

Innovation in AI Applications:
• Discover the latest advancements and tools in AI that are pushing the boundaries of drug discovery. This includes next-generation machine learning models, data analytics techniques, and computational methodologies that can predict drug efficacy, optimize drug design, and personalize treatment approaches.

Collaborative Methods:
• Build valuable connections with industry leaders, innovators, and researchers from across the globe. The summit facilitates networking opportunities that encourage collaborations and partnerships, fostering a community that supports and drives forward the collective goal of enhancing drug discovery through AI technologies.

2024 Speakers

Peter Clark
VP Computational Drug Design, Novo Nordisk

Jacob Berlin
CEO, Terray Therapeutics

Mark Adams
Venture Capital Partner, Two Bear Capital

Lu Zhang
Founder & Managing Partner, Fusion Fund

Zachary Webel
Data Scientist and Applied Mathematician, FDA

Lena Dolgikh
Head of Computational Chemistry, Monte Rosa Therapeutics

Ed Addison
Executive Chairman & Acting CEO, CLOUD PHARMACEUTICALS

Zhiyong (Sean) Xie
VP & Head of AI & Data Science, Xellarbio

Arvind Rao
Associate Professor Computational Medicine & Bioinformatics, University of Michigan

Monica Wang
Head of Biologics & Novel Modality Discovery Capabilities & Products, Scientific Informatics, Takeda

Simon Beaulah
SVP Precision Drug Repositioning, PRECISIONLIFE

Petrina Kamya
Global Head of AI Platforms, VP Insilico Medicine President, Insilico Medicine Canada Inc.

Rohit Arora
Innovation Lead, Novo Nordisk

Ari Allyn-Feuer
Director AI Product, GSK

Sriram Chandrasekaran
Associate Professor, Biomedical Engineering, University of Michigan

Mani Foroohar
Senior Managing Director Biotechnology Analyst, Leerink

Nevin Gerek Ince
Director Data & Solutions Engineering, Novo Nordisk

Zoran Krunic
Principal Product Manager, Amgen

Hayley Donnella
Director of Computational Oncology, Recursion

Lauris Kemp
Partner & Patent Attorney, HGF

Daniyal Hussain
Executive Director of Technology Business Development, GSK

Yu Qiu
Head of AI Innovation - Antibody Digital Biologics Platform, Sanofi

Yang-ming Zhu
SVP Head of Engineering (AI & ML), Superluminal

Chirag Sacher
Director Portfolio Innovation, Novartis

Julian Hess
Computational Scientist, Broad Institute of MIT & Harvard

Elena Diaz Cecilia
Senior Director, External Innovation, Janssen R&D

Peter McLean
Director Data Science, Recursion

Claire Leurent
Managing Director, Abbvie Ventures

Aiden Acever
VP, Insight Partners

Xia Ning
Professor, Ohio State University

Jackie Hunter
CEO, OI Pharma Partners

Ethan Pickering
Head of Data Science & Machine Learning Research, Bayer

Soujanya Bhumkar
Co-Founder, Gen1e Lifesciences

Ashwini Ghogare
Head of AI & Automation in Drug Discovery, MilliporeSigma

Charles O’Donnell
Vice President Head of Computational Genomics & Data Sciences, Omega Therapeutics

Brendan Frey
Founder & Chief Innovation Officer, Deep Genomics

Duncan Ng
Vice President, Solutions Engineering, Vultr

June Guo
VP, AI & ML, Athos

Stef van Grieken
Co-Founder & CEO, Cradle

Tejaswi Iyyanki
Principal Scientist, Sanofi

Edward Miller
Senior Director, Protein Structure Modelling, Schrodinger

2024 Partners

LEAD PARTNER:
• Millipore Sigma

GOLD PARTNERS:
• Cradle
• Fovus
• Fronteo

SILVER PARTNERS:
• Deep Genomics
• HGF
• IPA
• Vultr

BRONZE PARTNER:
• Promethium

TECH TEST LAB PARTNERS:
• Netabolics
• ReSync